Thursday, February 16, 2012 1:20:47 PM
To Chade: save your dime. Baker and Fong can't disclose jack
(to ANYone), no matter how many shares they hold. To do otherwise would be an instant violation of insider trading rules and they could well find themselve being frog-legged to a waiting U.S. Marshal's prisoner van.
If you want to know what they are thinking, then begin to know what they are up against. READ the 3rd Quarter financials like you might READ and understand the sports pages. If you don't understand what they mean, then pay some accountant friend a couple of hundred bucks or soto review them for you. As is often the case, 'past is prologue'. Then ask that accountanting friend to spill his or her guts about what they've examined. They'll be more than happy to do so.
(to ANYone), no matter how many shares they hold. To do otherwise would be an instant violation of insider trading rules and they could well find themselve being frog-legged to a waiting U.S. Marshal's prisoner van.
If you want to know what they are thinking, then begin to know what they are up against. READ the 3rd Quarter financials like you might READ and understand the sports pages. If you don't understand what they mean, then pay some accountant friend a couple of hundred bucks or soto review them for you. As is often the case, 'past is prologue'. Then ask that accountanting friend to spill his or her guts about what they've examined. They'll be more than happy to do so.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
